Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
J Hepatol
; 59(5): 1107-17, 2013 Nov.
Article
em En
| MEDLINE
| ID: mdl-23835194
Palavras-chave
APC; CBP; CK1; CREB-binding protein; CSC; DIFs; Dickkopf; Dkk; Drug discovery; Dvl/Dsh; FZD; GSK3ß; Gpc3; HCC; Hepatocellular carcinoma; Kremen; Krm; NFAT; NLK; Nemo-like kinase; PCP; PKC; Pygo; R-spondin; Rspo; SCF; Skp1/cullin F-box complex; T-cell factor/lymphoid enhancer factor; TCF/LEF; TLE-1; Therapy; Wif1; Wnt inhibitory protein-1; Wnt pathway; adenomatous polyposis coli protein; beta-transducin repeat containing protein; cancer stem cells; casein kinase 1; differentiation-inducing factors; disheveled; frizzled; glycogen synthase kinase 3ß; glypican-3; hepatocellular carcinoma; nuclear factor of activated T cell; planar cell polarity; protein kinase C; pygopus; sFRP; secreted FZD-related proteins; transducin like enhancer-1; ß-TRCP
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transdução de Sinais
/
Proteínas Wnt
/
Terapia de Alvo Molecular
/
Neoplasias Hepáticas
/
Antineoplásicos
Tipo de estudo:
Prognostic_studies
/
Screening_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article